Home Home Home Inbox Home Search

Event

Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step-Down to Mometasone Monotherapy [Board No. P871]

Location: Board no. P871
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Nicholas Ryan

MD
Merck & Co., Inc.

Robert A. Nathan

MD
Asthma and Allergy Associates

Stephen J. Lane

MD, PhD
Tallaght Hospital

Davis Gates

MD
Merck & Co., Inc.

Cindy L. Weinstein

MD
Merck & Co., Inc.

Xiaoli Zhang

MD
Merck & Co., Inc.

Tulin Shekar

MD
Merck & Co., Inc.

Ioana O. Agache

MD
Faculty of Medicine, Transylvania University

View Abstract

Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step-Down to Mometasone Monotherapy

Parent Sessions

  • A34 - ASTHMA CLINICAL STUDIES I
    05-20-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search